Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2013	12-2012	12-2011	12-2010	12-2009
Assets
Current Assets
Cash & Cash Equivalents	65,187	37,814	50,454	30,713	N/A
Marketable Securities	90,116	72,238	N/A	N/A	N/A
Receivables	5,857	9,267	7,426	3,745	N/A
Other current assets	0	0	1,946	0	0
TOTAL	$166,644	$128,301	$65,589	$36,288	$N/A

Non-Current Assets
PPE Net	13,364	6,297	6,206	7,458	N/A
Intangibles	11,650	12,780	13,100	13,420	0
Other Non-Current Assets	759	1,596	404	411	0
TOTAL	$25,773	$20,673	$19,710	$21,289	$N/A

Total Assets	$192,417	$148,974	$85,299	$57,577	$N/A

Liabilities
Current Liabilities
Short Term Debt	8,248	2,373	N/A	N/A	N/A
Accounts payable and accrued liabilities	38,814	25,644	17,511	1,440	0
Accrued Expenses	N/A	N/A	N/A	7,256	N/A
Other current liabilities	1,336	1,153	125	454	N/A
TOTAL	$57,734	$38,520	$26,151	$16,325	$N/A

Non-Current Liabilities
Long Term Debt	103,427	37,482	N/A	N/A	N/A
Deferred Revenues	9,336	9,350	7,712	6,462	N/A
aiOther Non-Current Liabilities	7,835	8,097	1,992	809	0
TOTAL	$178,148	$116,971	$80,839	$68,932	$N/A

Total Liabilities	$235,882	$155,491	$106,990	$85,257	$N/A

Shareholders' Equity
Shares Outstanding, K	10,304	9,590	N/A	N/A	N/A
Common Shares	1,025	958	118	111	N/A
Retained earnings	-572,245	-442,116	-350,839	-271,616	N/A
Other shareholders' equity	-24	-38	268,799	192,284	0
TOTAL	$-43,465	$-6,517	$-21,691	$-27,680	$N/A

Total Liabilities And Equity	$192,417	$148,974	$85,299	$57,577	$0